88 related articles for article (PubMed ID: 14533495)
1. Foot pump prophylaxis for deep venous thrombosis-rate of effective usage following knee and hip arthroplasty.
Charalambous C; Cleanthous S; Tryfonidis M; Goel A; Swindell R; Ellis D
Int Orthop; 2003; 27(4):208-10. PubMed ID: 12715239
[TBL] [Abstract][Full Text] [Related]
2. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
4. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
5. [Thrombosis prophylaxis in orthopaedic surgery: considerations and uncertainties].
Ettema HB; Hoppener MR; Büller HR; Henny ChP; Verheyen CC
Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1842-7. PubMed ID: 14533495
[TBL] [Abstract][Full Text] [Related]
6. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
7. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
8. Prevention of venous thromboembolism in high-risk surgical and medical patients.
Prandoni P; Sabbion P; Tanduo C; Errigo G; Zanon E; Bernardi E
Semin Vasc Med; 2001; 1(1):61-70. PubMed ID: 15199515
[TBL] [Abstract][Full Text] [Related]
9. Deep vein thrombosis prophylaxis: a comprehensive approach for total hip and total knee arthroplasty patient populations.
Miric A; Lombardi P; Sculco TP
Am J Orthop (Belle Mead NJ); 2000 Apr; 29(4):269-74. PubMed ID: 10784014
[TBL] [Abstract][Full Text] [Related]
10. Rationale for low-molecular-weight heparin prophylaxis after total knee arthroplasty.
Colwell CW; Hardwick ME
Clin Orthop Relat Res; 2006 Nov; 452():181-5. PubMed ID: 17016231
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
